Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis

Explore clinical trials studying Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

291 public trials 23 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis trial results

Completed

A Study for Tysabri Participant Preference

NCT05304520

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Neurozentrum am Königsplatz Augsburg; Dres. Müller und Schmid Augsburg, Germany
  • Praxis Dr. Schöll Bad Homburg, Germany
  • Caritas Krankenhaus Bad Mergentheim Bad Mergentheim, Germany
  • Neurologische Praxis Dr. med. Boris-Alexander Kallmann Bamberg, Germany
View all 40 locations
View Trial Details
Completed

A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis

NCT02545868

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • North Central Neurology Associates Cullman, Alabama, United States
  • Territory Neurology and Research Institute Tucson, Arizona, United States
  • Fullerton Neurology and Headache Center Fullerton, California, United States
  • Scripps Clinic La Jolla, California, United States
View all 22 locations
View Trial Details
Completed

Study on the Effectiveness of EGb 761® vs Placebo Used for Cognitive Impairment in Patients With Multiple Sclerosis

NCT00276341

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cognition Disorders, +9 more
Locations
  • Centre Hospitalier du Pays d'Aix Aix-en-Provence, France
  • Hôpital Nord - CHU d'Amiens Amiens, France
  • Hôpital J. Minjoz Besançon, France
  • CHU de Bordeaux Bordeaux, France
View all 30 locations
View Trial Details
Completed

Long Term Special Drug Use-results Surveillance for Mayzent in SPMS Patients

NCT04593927

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Novartis Investigative Site Anjo, Aichi-ken, Japan
  • Novartis Investigative Site Hekinan, Aichi-ken, Japan
  • Novartis Investigative Site Ichinomiya, Aichi-ken, Japan
  • Novartis Investigative Site Kariya, Aichi-ken, Japan
View all 174 locations
View Trial Details
Completed

A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis

NCT01194570

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Phoenix Neurological Associates Ltd Phoenix, Arizona, United States
  • Barrow Neurology Clinic Phoenix, Arizona, United States
  • Mayo Clinic- Scottsdale Scottsdale, Arizona, United States
  • Arizona Neuroscience Research LLC Phoenix, Arkansas, United States
View all 184 locations
View Trial Details
Completed

Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS

NCT03799718

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +9 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Stanford University School of Medicine Redwood City, California, United States
  • The Mount Sinai Hospital New York, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View Trial Details

Related conditions